I wouldn't give them an "F" just yet, though their boring lack of communication sure is enough to give one a case of the "Zzzzzz's". I give them a "D" right now. If we don't hear anything substantial related to trial update(s) and the closing of the re-organization by the end of Q2 then this will be downgraded to an "F."

The NYAS: Epigenetics and Beyond eBriefing featuring Eric Campeau's talk from April 28th will be available soon, possibly by the end of the month. We have that to look forward too. However, we need an actual corporate update webcast and concrete info about the status of the trial and the re-organization prior to June 30 to prevent the "D" to "F" downgrade, IMO.

BearDownAZ